An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS - PubMed (original) (raw)
. 1985 May;315(6015):151-4.
doi: 10.1038/315151a0.
- PMID: 2986016
- DOI: 10.1038/315151a0
An HTLV-III peptide produced by recombinant DNA is immunoreactive with sera from patients with AIDS
N T Chang et al. Nature. 1985 May.
Abstract
Human T-cell lymphotropic retrovirus type III (HTLV-III), also called lymphadenopathy-associated virus (LAV), has been identified as the aetiological agent of acquired immune deficiency syndrome (AIDS). The sera of most patients with AIDS or AIDS-related complexes, and of asymptomatic individuals infected with HTLV-III, contain antibodies against antigens of HTLV-III. The characterization of these antibodies and their corresponding viral antigens is important not only for understanding immunity against HTLV-III and the pathology of AIDS, but also for the development of diagnostic methods and preventive vaccine for AIDS. Following the successful establishment of a long-term T-cell line permissive for HTLV-III replication, large quantities of virus have been produced, facilitating the purification of viral proteins and the development of mouse monoclonal antibodies against several viral antigens. More recently, the structure of HTLV-III proviral DNA has been elucidated. We now report the production, by genetic engineering methods, of a peptide encoded by a gene segment of HTLV-III. A 1.1-kilobase (kb) EcoRI DNA segment from an isolate of HTLV-III was inserted into a lpp and lac promoter-coupled expression vector, pIN-III-ompA. Escherichia coli transformants of this plasmid produced a peptide of relative molecular mass (Mr) 15,000 (15K) which was strongly immunoreactive with anti-HTLV-III antibodies present in sera from AIDS patients. Lysates of the clones expressing this 15K peptide inhibited the reactivity of the p31 virion protein with AIDS sera, suggesting that it is a fragment of the viral p31 protein. The peptide reacted with sera from all 20 AIDS patients but none of the 8 normal controls tested. These results suggest that the peptide may be useful for detecting anti-HTLV-III antibodies in blood samples.
Similar articles
- Human T-cell lymphotropic virus type III (HTLV-III) core antigens: synthesis in Escherichia coli and immunoreactivity with human sera.
Ghrayeb J, Kato I, McKinney S, Huang JJ, Chanda PK, Ho DD, Sarangadharan MG, Chang TW, Chang NT. Ghrayeb J, et al. DNA. 1986 Apr;5(2):93-9. doi: 10.1089/dna.1986.5.93. DNA. 1986. PMID: 3011373 - Expression in Escherichia coli of open reading frame gene segments of HTLV-III.
Chang NT, Chanda PK, Barone AD, McKinney S, Rhodes DP, Tam SH, Shearman CW, Huang J, Chang TW, Gallo RC, et al. Chang NT, et al. Science. 1985 Apr 5;228(4695):93-6. doi: 10.1126/science.2983429. Science. 1985. PMID: 2983429 - Etiology of AIDS: biological and biochemical characteristics of HTLV-III.
Markham PD, Shaw GM, Salahuddin SZ, Hahn B, Sarngadharan MG, Gallo RC. Markham PD, et al. Adv Exp Med Biol. 1985;187:13-34. doi: 10.1007/978-1-4615-9430-7_2. Adv Exp Med Biol. 1985. PMID: 2994417 Review. - Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M, McLane MF, Kanki P, Allan J, Kitchen L, Lee TH. Essex M, et al. Cancer Res. 1985 Sep;45(9 Suppl):4534s-4538s. Cancer Res. 1985. PMID: 2990682 Review.
Cited by
- Detection of antibodies to human T-lymphotropic virus type III by using a synthetic peptide of 21 amino acid residues corresponding to a highly antigenic segment of gp41 envelope protein.
Wang JJ, Steel S, Wisniewolski R, Wang CY. Wang JJ, et al. Proc Natl Acad Sci U S A. 1986 Aug;83(16):6159-63. doi: 10.1073/pnas.83.16.6159. Proc Natl Acad Sci U S A. 1986. PMID: 2426711 Free PMC article. - Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.
Robey WG, Arthur LO, Matthews TJ, Langlois A, Copeland TD, Lerche NW, Oroszlan S, Bolognesi DP, Gilden RV, Fischinger PJ. Robey WG, et al. Proc Natl Acad Sci U S A. 1986 Sep;83(18):7023-7. doi: 10.1073/pnas.83.18.7023. Proc Natl Acad Sci U S A. 1986. PMID: 3018753 Free PMC article. - Major antigenic region on the integrase (IN) protein of human immunodeficiency virus type 1 determined by reactivity of human sera and a monoclonal antibody to IN protein.
Tachibana Y, Yasuda A, Kurata T, Oka S, Shimada K, Kojima A. Tachibana Y, et al. Clin Diagn Lab Immunol. 1994 Nov;1(6):678-83. doi: 10.1128/cdli.1.6.678-683.1994. Clin Diagn Lab Immunol. 1994. PMID: 8556520 Free PMC article. - Localization of immunogenic domains in the human immunodeficiency virus type 2 envelope.
Huang ML, Essex M, Lee TH. Huang ML, et al. J Virol. 1991 Sep;65(9):5073-9. doi: 10.1128/JVI.65.9.5073-5079.1991. J Virol. 1991. PMID: 1714524 Free PMC article. - Distinct IgG recognition patterns during progression of subclinical and clinical infection with lymphadenopathy associated virus/human T lymphotropic virus.
Lange JM, Coutinho RA, Krone WJ, Verdonck LF, Danner SA, van der Noordaa J, Goudsmit J. Lange JM, et al. Br Med J (Clin Res Ed). 1986 Jan 25;292(6515):228-30. doi: 10.1136/bmj.292.6515.228. Br Med J (Clin Res Ed). 1986. PMID: 3004634 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical